ACM
LYRA

Altium Capital Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Altium Capital Management’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-104
Closed -$59K – 135
2020
Q4 		$59K Buy
+104
New +$58.6K 0.02% 94

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Altium Capital Management's LYRA Position: Q1 2021 in Review

Altium Capital Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2021, closing a stake of 104 shares — an estimated $59K sold.

Altium Capital Management first reported a position in LYRA in Q4 2020 and held it in 1 quarter. The position peaked at $59K in Q4 2020. 49 funds tracked by Wall St. Rank hold LYRA as of Q1 2021.

  • Altium Capital Management reported no remaining LYRA THERAPEUTICS INC position as of Q1 2021 after selling out during the quarter.
  • Altium Capital Management sold 104 LYRA THERAPEUTICS INC shares in Q1 2021, an estimated $59K.
  • Altium Capital Management first reported a position in LYRA THERAPEUTICS INC in Q4 2020 and held it in 1 quarter.
  • Altium Capital Management's LYRA THERAPEUTICS INC position peaked at $59K in Q4 2020.
  • 49 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2021.

Based on Altium Capital Management's 13F filing for Q1 2021, filed 6 May 2021.